tiprankstipranks
Advertisement
Advertisement

MBRX Stock Latest News

Moleculin Biotech issued liposomal Annamycin patent in Hong Kong
The FlyMoleculin Biotech issued liposomal Annamycin patent in Hong Kong
2d ago
MBRX
Moleculin Secures New Hong Kong Patent for Annamycin
PremiumCompany Announcements
Moleculin Secures New Hong Kong Patent for Annamycin
2d ago
8K
MBRX
Moleculin Highlights Promising Preclinical Data for L-ANN
PremiumCompany Announcements
Moleculin Highlights Promising Preclinical Data for L-ANN
17d ago
8K
MBRX
Moleculin Biotech Stockholders Approve Warrant Share Issuance
PremiumCompany Announcements
Moleculin Biotech Stockholders Approve Warrant Share Issuance
25d ago
8K
MBRX
Moleculin Biotech management to meet with Maxim
PremiumThe Fly
Moleculin Biotech management to meet with Maxim
1M ago
MBRX
Moleculin Biotech files to sell 6.37M shares of common stock for holders
PremiumThe FlyMoleculin Biotech files to sell 6.37M shares of common stock for holders
1M ago
MBRX
Moleculin Biotech announces enrollment milestone in MIRACLE trial
Premium
The Fly
Moleculin Biotech announces enrollment milestone in MIRACLE trial
2M ago
MBRX
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
Premium
Company Announcements
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
2M ago
8K
MBRX
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
PremiumRatings
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
2M ago
MBRX
Moleculin Biotech Updates Investors with New Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Updates Investors with New Corporate Presentation
2M ago
8K
MBRX
Moleculin Biotech reports FY25 EPS ($28.42) vs. ($189.14) last year
PremiumThe Fly
Moleculin Biotech reports FY25 EPS ($28.42) vs. ($189.14) last year
2M ago
MBRX
Moleculin Biotech sees cash runway into 3Q26
PremiumThe Fly
Moleculin Biotech sees cash runway into 3Q26
2M ago
MBRX
MBRX Earnings this Week: How Will it Perform?
PremiumPre-EarningsMBRX Earnings this Week: How Will it Perform?
2M ago
MBRX
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
Premium
Company Announcements
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
3M ago
8K
MBRX
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
Premium
Ratings
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
3M ago
MBRX
Moleculin Biotech announces exercise of warrants for $8.3M gross proceeds
PremiumThe Fly
Moleculin Biotech announces exercise of warrants for $8.3M gross proceeds
3M ago
MBRX
Moleculin Biotech Issues New Investor Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Issues New Investor Corporate Presentation
3M ago
8K
MBRX
Moleculin Reports Positive Progress in MIRACLE AML Trial
PremiumCompany Announcements
Moleculin Reports Positive Progress in MIRACLE AML Trial
3M ago
8K
MBRX
Moleculin approach first unblinding of data from Phase 2B/3 study of Annamycin
PremiumThe Fly
Moleculin approach first unblinding of data from Phase 2B/3 study of Annamycin
3M ago
MBRX
Moleculin Biotech announces notice of allowance for JPO covering Annamycin
PremiumThe FlyMoleculin Biotech announces notice of allowance for JPO covering Annamycin
3M ago
MBRX
Moleculin Gains Japanese Patent Allowance for Annamycin
Premium
Company Announcements
Moleculin Gains Japanese Patent Allowance for Annamycin
3M ago
8K
MBRX
Moleculin Biotech announces launch of CEO Corner platform
Premium
The Fly
Moleculin Biotech announces launch of CEO Corner platform
3M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >